Pharmacological Management of Primary Open-Angle Glaucoma: Second-Line Options and Beyond

Author： Webers Carroll A.B. Beckers Henny J.M. Nuijts Rudy M.M.A. Schouten Jan S.A.G.

ISSN： 1170-229X

Source： Drugs & Aging, Vol.25, Iss.9, 2008-01, pp. : 729-759

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prospects for Genetic Intervention in Primary Open-Angle Glaucoma

By Wirtz M.K. Acott T.S. Samples J.R. Morrison J.C.

Drugs & Aging, Vol. 13, Iss. 5, 1998-11 ,pp. : 333-340

Adis International

Access to resources Recommend Favorite

Brimonidine: A Review of its Pharmacological Properties and Clinical Potential in the Management of Open-Angle Glaucoma and Ocular Hypertension

By Adkins J.C. Balfour J.A.

Drugs & Aging, Vol. 12, Iss. 3, 1998-03 ,pp. : 225-241

Adis International

Access to resources Recommend Favorite

Brinzolamide: A Review of Its Use in the Management of Primary Open-Angle Glaucoma and Ocular Hypertension

By Cvetkovic R.S. Perry C.M.

Drugs & Aging, Vol. 20, Iss. 12, 2003-01 ,pp. : 919-947

Adis International

Access to resources Recommend Favorite

Pharmacogenomics of Open-Angle Glaucoma

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 6, Iss. 2, 2008-06 ,pp. : 121-125

Bentham Science Publishers

Access to resources Recommend Favorite

Travoprost/timolol fixed combination in the management of open-angle glaucoma: a clinical review

By Denis Philippe

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 3, 2011-02 ,pp. : 463-471

Informa Healthcare

Access to resources Recommend Favorite